Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 539 results for "ranbaxy"

Religare Asset sale has nothing to do with Ranbaxy case: Sunil Godhwani
Livemint.com

Religare Asset sale has nothing to do with Ranbaxy case: Sunil...

We will be now focused around SME lending, health insurance and capital markets, says Religare Enterprises chairman and MD Sunil Godhwani Mumbai: For brothers Malvinder and Shivinder Singh who, in 2008, sold their stake in Ranbaxy Laboratories to ... Livemint.com, 1 month ago
[x]  

54 images for ranbaxy

Livemint.com, 1 month ago
FiercePharma, 1 month ago
Livemint.com, 1 month ago
Livemint.com, 1 month ago
Livemint.com, 1 month ago
Rediff.com, 2 months ago
Financial Express, 2 months ago
VC Circle, 2 months ago
VC Circle, 2 months ago
StatNews.com, 2 months ago

Ranbaxy whistle blower Dinesh Thakur suggests strict prosecution laws to fix drug industry

NEW DELHI: Dinesh Thakur, the famous whistle blower who highlighted data manipulation issues at top Indian drug maker Ranbaxy (now part of Sun Pharma), says the country needs strict criminal prosecution against suppliers of substandard drugs, a ...
 Economic Times1 month ago India needs strict prosecution laws to fix drug regulatory system: Ranbaxy whistleblower Dinesh Thakur  Economic Times1 month ago No rewards, only grief: How drug whistle-blowers in India have to fight a long battle  Economic Times2 months ago

Sun Pharma will be unstoppable if it integrates Ranbaxy well: Amit Rajan, Director, Celogen Life Science

In this interview with , Amit Rajan, Director, Celogen Life Science talks about Indian pharma companies and US FDA process. Edited excerpts: ET Now: What is your understanding of the news flow which has come for Indian pharma sector? Amit Rajan: ...
 Economic Times2 weeks ago
Rediff.com

Don't need to sell assets, can pay fine: Ranbaxy brothers

Former promoters of Ranbaxy tell Delhi High Court they can pay fine to DaiichiFormer Ranbaxy promoters Malvinder Singh and Shivinder Singh on Tuesday assured the Delhi High Court they would keep assets secure to be in a position to make the Rs 3,500-crore (Rs 35-billion) payment to Japanese conglomerate Daiichi Sankyo, which had in 2008 bought a majority stake in the Indian pharma major. A Singapore arbitration court recently imposed this fine after it found the Singh brothers guilty of ...
 Rediff.com2 months ago Overwhelming deals, overdue diligence  VC Circle2 months ago Singh brothers told to pay Rs 2,562-crore fine to Daiichi  Business Standard2 months ago Singh bros to challenge ₹2,562 cr fine for hiding Ranbaxy info from Daiichi  Business Line2 months ago
[x]  

Sun Pharmaceutical Ind: The recovery phase

Merger hiccups with Ranbaxy and regulatory troubles will soon be resolved June 26, 2016: The volatility in Indian equities has had a negative rub off on many bluechip pharma stocks. The stock of drug major, Sun Pharmaceutical Industries, is one such. Besides ...
 Business Line4 weeks ago
Livemint.com

Sun Pharma projects 8% revenue growth for FY17

US FDA visit due at Halol plant and one Ranbaxy plant  
 Business Line1 month ago FDA inspections at Ranbaxy plants expected in FY17, says Dilip Shanghvi  Livemint.com1 month ago

More trouble for Ranbaxy as central regulator finds deficiencies

Joint inspections with eight other regulators carried at six of Ranbaxy’s laboratories in Himachal Pradesh found discrepancies in testing, stability standards and expiry dates, among other standards.
 Money Control2 months ago Central drug regulator moves SC against Ranbaxy over lapses  Money Control2 months ago
Rediff.com

Ranbaxy's Singh brothers asked to pay over Rs 2,500 crore penalty

Malvinder Singh and Shivinder Singh have been asked to pay the fine for misrepresenting and concealing information to Daiichi during their stake sale to the Japanese company.
 DNA2 months ago Court asks Singh brothers to pay Rs 2,500 crore to Daiichi  Business Standard2 months ago Court asks Singh brothers to pay Daiichi Rs 2,500 cr  The Financial Chronicle2 months ago Rs 3,500-cr fine on Singh bros, not Rs 2,562 cr: Daiichi  Rediff.com2 months ago

Religare Enterprises to split into three independent listed units

MUMBAI: Religare Enterprises, the company majority owned by the family that once were the promoters of Ranbaxy Labs, on Friday decided to split into three independent listed entities handling lending operations through the NBFC arm, running the ...
 Times of India1 month ago
Moneycontrol.com

Daiichi Sankyo moves further to cut legacy Ranbaxy ties

Tokyo-based Daiichi Sankyo has further cut legacy ties to Ranbaxy Laboratories in a mutual agreement with Sun Pharmaceutical Industries to terminate transaction agreements connected to the firm. Mumbai-based Sun bought Ranbaxy in an all-stock ...
 FiercePharma1 month ago Sun Pharma, Daiichi terminate transaction pacts  Moneycontrol.com2 months ago Sun Pharma shares surge over 4% on termination of transition pact with Daiichi  Financial Express1 month ago Sun Pharma shares surge over 5% on termination of transition pact with Daiichi  Financial Express1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - ranbaxy
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less